Fig. 3

Kaplan–Meier survival curves depict patient outcomes from the initiation of TAS-102 therapy until death, stratified by the presence or absence of the rs351855 FGFR4 polymorphism. Time is represented on the x-axis, while survival probability is depicted on the y-axis. The number of patients at risk is reported below the figure, with data categorized based on FGFR4 polymorphism status